July 17 Abbott Laboratories reported
better-than-expected quarterly earnings on Wednesday as strong
demand for its nutritional products offset lower sales of
medical devices and generic prescription drugs.
The company, which in January spun off its branded
prescription drugs business into a new company called AbbVie Inc
, earned $476 million, or 30 cents per share, from
continuing operations, compared with $411 million, or 26 cents
per share, in the year-earlier period.
Excluding special items, Abbott earned 46 cents per share.
Analysts, on average, expected 44 cents, according to Thomson